Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Morphy

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 30, 2010
The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of painDerek Angus, Matilda Bingham, Dawn Buchanan, et al.
Science (New York, N.Y.)|May 12, 2018
Asymmetric nucleophilic fluorination under hydrogen bonding phase-transfer catalysisGabriele Pupo, Francesco Ibba, David M H Ascough, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2011
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonistsJames Baker, Matilda Bingham, Ruth Blackburn-Munro, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonistsElizabeth M Moir, Kazuya Yoshiizumi, Jim Cairns, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|November 30, 2010
The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of painDerek Angus, Matilda Bingham, Dawn Buchanan, et al.
Science (New York, N.Y.)|May 12, 2018
Asymmetric nucleophilic fluorination under hydrogen bonding phase-transfer catalysisGabriele Pupo, Francesco Ibba, David M H Ascough, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2011
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonistsJames Baker, Matilda Bingham, Ruth Blackburn-Munro, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonistsElizabeth M Moir, Kazuya Yoshiizumi, Jim Cairns, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 3